Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.11.5455

Luteolin Induced-growth Inhibition and Apoptosis of Human Esophageal Squamous Carcinoma Cell Line Eca109 Cells in vitro  

Wang, Ting-Ting (Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University)
Wang, Shao-Kang (Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University)
Huang, Gui-Ling (Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University)
Sun, Gui-Ju (Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.11, 2012 , pp. 5455-5461 More about this Journal
Abstract
Luteolin is a plant flavonoid which exhibits anti-oxidative, anti-inflammatory and anti-tumor effects. However, the antiproliferative potential of luteolin is not fully understood. In this study, we investigated the effect of luteolin on cell cycling and apoptosis in human esophageal squamous carcinoma cell line Eca109 cells. MTT assays showed that luteolin had obvious cytotoxicity on Eca109 with an $IC_{50}$ of $70.7{\pm}1.72{\mu}M$ at 24h. Luteolin arrested cell cycle progression in the G0/G1 phase and prevented entry into S phase in a dose- and time-dependent manner. as assessed by FCM. Luteolin induced apoptosis of Eca109 cells was demonstrated by AO/EB staining assay and annexin V-FITC/PI staining. Moreover, luteolin downregulated the expression of cyclin D1, survivin and c-myc, and it also upregulated the expression of p53, in line with the fact that luteolin was able to inhibit Eca109 cell proliferation.
Keywords
Luteolin; esophageal cancr; Eca109; cell cycle arrest; apopotosis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Wang LF, Lu A, Liu XX, et al (2011). The flavonoid Baohuoside-I inhibits cell growth and downregulates survivin and cyclin D1 expression in esophageal carcinoma via beta-catenindependent signaling. Oncol Rep, 26, 1149-56.
2 Altieri DC (2003). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene, 22, 8581-9.   DOI
3 Ashokkumar P, Sudhandiran G (2008). Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomed Pharmacother, 62, 590-7.   DOI
4 Cai X, Ye T, Liu C, et al (2011). Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells. Toxicol in Vitro, 25, 1385-91   DOI
5 Casagrande F, Darbon JM (2001). Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol, 61, 1205-15.   DOI
6 Chen Q, Liu SM, Chen JH, et al (2012). Luteolin Induces Mitochondria-dependent Apoptosis in Human Lung Adenocarcinoma Cell. Natl Prod Commun, 7, 29-32.
7 Cheng AC, Huang TC, Lai CS, et al (2005). Induction of apoptosis by luteolin through cleavage of Bcl-2 family in human leukemia HL-60 cells. Eur J Pharmacol, 509, 1-10.   DOI   ScienceOn
8 Chiu FL, Lin JK (2008). Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Prostate, 68, 61-71.   DOI
9 Choi AY, Choi JH, Yoon H, et al (2011). Luteolin induces apoptosis through endoplasmic reticulum stress and mitochondrial dysfunction in Neuro-2a mouse neuroblastoma cells. Eur J Pharmacol, 668, 115-26.   DOI
10 Doonan F, Cotter TG (2008). Morphological assessment of apoptosis. Methods, 44, 200-4.   DOI
11 Fan YH, Yuan JM, Wang RW, et al (2008). Alcohol, Tobacco and Diet in Relation to Esophageal Cancer: The Shanghai Cohort Study. Nutr Cancer, 60, 354-63.   DOI
12 Fotsis T, Pepper MS, Aktas E, et al (1997). Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res, 57, 2916-21.
13 Gao X, Cassidy A, Schwarzschild MA, et al (2012). Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology, 78, 1138-45.   DOI
14 Gao Y, Hu N, Han XY, et al (2011). Risk factors for esophageal and gastric cancers in Shanxi Province, China: A case-control study. Cancer Epidemiol, 35, E91-9.   DOI
15 Gehoff A, Basten O, Sprenger T, et al (2012). Optimal lymph node harvest in rectal cancer (UICC stages II and III) after preoperative 5-FU-based radiochemotherapy. Acetone compression is a new and highly efficient method. Am J Surg Pathol, 36, 202-13.   DOI
16 Globocan (2008). International Agency for Research on Cancer. (Version current at June 20, 2012).
17 Huang YT, Hwang JJ, Lee PP, et al (1999). Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Brit J Pharmacol, 128, 999-1010.   DOI   ScienceOn
18 Gorgoulis VG, Zacharatos PV, Manolis E, et al. (1998). Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene. Brit J Cancer, 77, 374-84.   DOI
19 He D, Ma X, Chen Y, et al (2012). Luteolin inhibits pyrogallolinduced apoptosis through the extracellular signal-regulated kinase signaling pathway. FEBS J, 279, 1834-43.   DOI
20 He J, Zhang RG, DZ (1995). Clinical significance of c-myc gene in esophageal squamous cell carcinoma. Natl med J China, 75, 94-6.
21 Ikeguchi M, Kaibara N (2002). survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma. Brit J Cancer, 87, 883-7.   DOI
22 Ikeguchi M, Yamaguchi K, Kaibara N (2003). Survivin gene expression positively correlates with proliferative activity of cancer cells in esophageal cancer. Tumor Biol, 24, 40-5.   DOI
23 Joensuu K, Hagstrom J, Leidenius M, et al (2011). Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases-elevated Bmi-1 expression in late breast cancer relapses. Virchows Arch, 459, 31-9.   DOI
24 Jones GJ, Heiss NS, Veale RB, et al. (1993). Amplification and expression of the TGF-alpha, EGF recptor and c-myc genes in 4 human esophageal squamous cell carcinoma lines. Bioscience Rep, 13, 303-312.   DOI
25 Kim MJ, Woo JS, Kwon CH, et al (2012). Luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines. Cell Biol Int, 36, 339-44.   DOI
26 Ju W, Wang X, Shi HL, et al (2007). A critical role of luteolininduced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappa B pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol, 71, 1381-8.   DOI
27 Kanda Y, Nishiyama Y, Shimada Y, et al (1994). Analysis of gene amplification and overexpression in human esophageal carcinoma cell lines. Int J Cancer, 58, 291-7.   DOI
28 Kato J, Kuwabara Y, Mitani M, et al (2001). Expression of survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy. Int J Cancer, 95, 92-5.   DOI   ScienceOn
29 Knowles LM, Zigrossi DA, Tauber RA, et al (2000). Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr Cancer, 38, 116-22.   DOI   ScienceOn
30 Ko WG, Kang TH, Lee SJ, et al (2002). Effects of luteolin on the inhibition of proliferation and induction of apoptosis in human myeloid leukaemia cells. Phytother Res, 16, 295-8.   DOI   ScienceOn
31 Komiya K, Sueoka-Aragane N, Sato A, et al (2010). Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer. Lung Cancer, 69, 232-8.   DOI
32 Lee HJ, Wang CJ, Kuo HC, et al (2005). Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol Appl Pharm, 203, 124-31.   DOI   ScienceOn
33 Lim DY, Park JHY (2005). Luteolin inhibits cell proliferation by inducing cell cycle arrest in G1 and G2/M phases in HT-29 human colon cancer cells. Faseb J, 19, A1693-4.
34 Lee LT, Huang YT, Hwang JJ, et al (2002). Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res, 22, 1615-27
35 Levine AJ (1997). p53, the cellular gatekeeper for growth and division. Cell, 88, 323-31.   DOI   ScienceOn
36 Lim DY, Jeong Y, Tyner AL, et al (2007). Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. Am J Physiol Gastr L, 292, G66-75.   DOI
37 Ma G, Yang CL, QuY, et al (2007). The flavonoid component isorhamnetin in vitro inhibits proliferation and induces apoptosis in Eca-109 cells. Chem Biol Interact, 167,153-60.   DOI
38 Massague J (2004). G1 cell-cycle control and cancer. Nature, 432, 298-306.   DOI
39 Malumbres M, Barbacid M (2009). Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer, 9, 153-66.   DOI
40 Master Z, Chaudhary A, Sutter TR, et al (2012). Effects of flavonoids on CYP1 expression in RL95-2 endometrial carcinoma cells. Food Chem, 133, 912-22.   DOI
41 Mayne ST, Risch HA, Dubrow R, et al (2001). Nutrient Intake and Risk of Subtypes of Esophageal and Gastric Cancer. Cancer Epidem Biomar, 10, 1055-62.
42 McCullough ML, Peterson JJ, Patel R, et al (2012). Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr, 95, 454-64.   DOI
43 Oze I, Matsuo K, Hosono S, et al (2010). Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population. Cancer Sci, 101, 1875-80.   DOI
44 Mosmann T (1983). Rapid colorimetric assay for cellular growth and survivial-application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55-63.   DOI   ScienceOn
45 Nogata Y, Sakamoto K, Shiratsuchi H, et al (2006). Flavonoid composition of fruit tissues of citrus species. Biosci Biotech Bioch, 70, 178-92.   DOI   ScienceOn
46 Ong CS, Zhou J, Ong CN, et al (2010). Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3beta-Cyclin D1 pathway. Cancer Lett, 298, 167-75.   DOI
47 Park CM, Jin KS, Cho CW, et al (2012). Luteolin inhibits inflammatory responses by downregulating the JNK, NF-${\kappa}$B, and AP-1 pathways in TNF-${\alpha}$ activated HepG2 cells. Food Sci Biotech, 21, 279-83.   DOI
48 Pera M, Gallego R, Montagut C, et al (2012). Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer. Ann Oncol, 23, 664-70.   DOI
49 Prives C, Hall PA (1999). The p53 pathway. J Pathol, 187, 112-26.   DOI   ScienceOn
50 Rosato A, Pivetta M, Parenti A, et al (2006). Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma. Int J Cancer, 119, 1717-22.   DOI
51 Sivagami G, Vinothkumar R, Preethy CP, et al (2012). Role of hesperetin (a natural flavonoid) and its analogue on apoptosis in HT-29 human colon adenocarcinoma cell line -A comparative study. Food Chem Toxicol, 50, 660-71.   DOI
52 Sasaki N, Toda T, Kaneko T, et al (2003). Protective effects of flavonoids on the cytotoxicity of linoleic acid hydroperoxide toward rat pheochromocytoma PC12 cells. Chem Biol Interact, 145, 101-16.   DOI
53 Schwartz GK, Shah MA (2005). Targeting the cell cycle: A new approach to cancer therapy. J Clin Oncol, 23, 9408-21.   DOI   ScienceOn
54 S Shi RX, Ong CN, Shen HM (2004). Luteolin sensitizes tumor necrosis factor-a-induced apoptosis in human tumor cells. Oncogene, 23, 7712-21.   DOI   ScienceOn
55 Su CC (2012). Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II. Exp Ther Med, 3, 555-9.   DOI
56 Sun MY, Han J, Duan JF, et al (2007). Novel antitumor activities of Kushen flavonoids in vitro and in vivo. Phytother Res, 21, 269-77.   DOI   ScienceOn
57 Taylor WR, Stark GR (2001). Regulation of the G2/M transition by p53. Oncogene, 20, 1803-15.   DOI   ScienceOn
58 Uehara A, Nakata M, Kitajima J, et al (2012). Internal and external flavonoids from the leaves of Japanese Chrysanthemum species (Asteraceae). Biochem Syst Ecol, 41, 142-9.   DOI
59 Veugelers PJ, Porter G A, Guernsey DL, et al (2006). Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus, 19, 321-8.   DOI
60 Vogelstein B, Lane D, Levine AJ (2000). Surfing the p53 network. Nature, 408, 307-10.   DOI   ScienceOn